Breast Cancer Diagnostics Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027

The global breast cancer diagnostics market is forecasted to reach USD 8,738.9 Million by 2027, according to a new report by Reports and Data. The breast cancer diagnostics market is observing high growth due to the rising occurrences of breast cancer across the globe. Breast cancer is the most common type of cancer occurring in women. There were more than 2 million new cases of breast cancer in 2018. Belgium, Luxembourg, and the Netherlands are the countries with the highest rates of occurrences of breast cancer in the year 2018 across the globe. According to Global Health Estimates, WHO 2013, it is projected that more than 508,000 women deceased in 2011 owing to breast cancer. It has been found that around 50% of breast cancer cases and nearly 58% of deaths happen in less developed economies as compared to developed economies. The global survival rates from the disease vary greatly, ranging from around 80% in North America, Japan, and Sweden to nearby 60% in middle-income nations and lower than 40% in low-income nations. Hence, the implementation of breast diagnostics to screen and detect malignant cells in the human breast is driving the growth of the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3690

Market Dynamics:

Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.

Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2027.

Further key findings from the report suggest

• Mammography contributed to a significant market share in 2019. Mammography screening often enables the detection of cancers at an early stage of development, whereby treatment may be done without chemotherapy.

• The market is dominated by the female population, with male patients contributing to less than 1.0% of the market share in 2019

• Hospitals dominated the breast cancer diagnostics market in 2019. The factors including well-resourced operating & diagnostic rooms, higher purchasing power, the existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.

• North America contributed to the largest breast cancer diagnostics market share in 2019. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare diagnostic facilities, the surging incidence of the disease, and the enactment of numerous initiatives for raising awareness about the disease in the region.

• Key participants include Myriad Genetics Inc., Hologic Inc., Danaher Corporation, CR Bard Inc., Genomic Health, NanoString Technologies Inc., Becton, Dickinson, and Company, Koninklijke Philips NV, Devicor Medical Products Inc., and Abbott Laboratories, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3690

For the purpose of this report, Reports and Data has segmented into the global breast cancer diagnostics market on the basis of test type, breast cancer type, end-user, and region:

Test Type Outlook (Revenue, USD Billion; 2017-2027)

• Imaging
• Biopsy
• Genomic Test
• Blood Test
• Others

Breast Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

• Ductal Carcinoma In Situ
• Invasive Ductal Carcinoma
• Inflammatory Breast Cancer
• Metastatic Breast Cancer

End-User Outlook (Revenue, USD Billion; 2017-2027)

• Hospitals & Clinics
• Diagnostic Centers
• Research Institutes
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
o U.S
o Canada
• Europe
o Germany
o UK
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o Japan
o South Korea
o Rest of APAC
• MEA
o Saudi Arabia
o UAE
o Rest of MEA
• Latin America
o Brazil
o Rest of LATAM
o
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3690

Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.

Read More Related Reports:-

Human Growth Hormone Market @ https://www.google.fi/url?q=https://www.reportsanddata.com/report-detail/human-growth-hormone-hgh-market

Blood Bags Market @ https://www.google.sk/url?q=https://www.reportsanddata.com/report-detail/blood-bags-market

Patient Temperature Management Devices Market @ https://www.google.mu/url?q=https://www.reportsanddata.com/report-detail/patient-temperature-management-devices-market

Cochlear Implant (CI) Market @ https://www.google.com.sv/url?q=https://www.reportsanddata.com/report-detail/cochlear-implant-ci-system-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.